{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T09:24:26Z","timestamp":1793093066047,"version":"4.5.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T00:00:00Z","timestamp":1738540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T00:00:00Z","timestamp":1738540800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"FAVA MULTI"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Diagn Ther"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1007\/s40291-025-00770-0","type":"journal-article","created":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T13:40:00Z","timestamp":1738590000000},"page":"367-380","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Identification of Somatic Genetic Variants in Superficial Vascular Malformations by Liquid Biopsy in a Cohort of 88 Patients from a French Hospital"],"prefix":"10.1007","volume":"29","author":[{"given":"Franck Neil","family":"El Sissy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annouk","family":"Bisdorff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Perrier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erell","family":"Guillerm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9r\u00f4me","family":"Denis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00f6etitia","family":"Favre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathilde","family":"Aubertin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e9lanie","family":"Eyries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Coulet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,3]]},"reference":[{"key":"770_CR1","doi-asserted-by":"publisher","first-page":"e203","DOI":"10.1542\/peds.2014-3673","volume":"136","author":"M Wassef","year":"2015","unstructured":"Wassef M, Blei F, Adams D, Alomari A, Baselga E, Berenstein A, et al. Vascular anomalies classification: recommendations from the International Society for the Study of Vascular Anomalies. Pediatrics. 2015;136:e203\u201314.","journal-title":"Pediatrics"},{"key":"770_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.sempedsurg.2020.150967","volume":"29","author":"H-L Nguyen","year":"2020","unstructured":"Nguyen H-L, Boon LM, Vikkula M. Genetics of vascular anomalies. Semin Pediatr Surg. 2020;29: 150967.","journal-title":"Semin Pediatr Surg"},{"key":"770_CR3","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s10456-016-9538-1","volume":"20","author":"JA Couto","year":"2017","unstructured":"Couto JA, Ayturk UM, Konczyk DJ, Goss JA, Huang AY, Hann S, et al. A somatic GNA11 mutation is associated with extremity capillary malformation and overgrowth. Angiogenesis. 2017;20:303\u20136.","journal-title":"Angiogenesis"},{"key":"770_CR4","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1111\/jdv.18046","volume":"36","author":"FN El Sissy","year":"2022","unstructured":"El Sissy FN, Wassef M, Faucon B, Salvan D, Nadaud S, Coulet F, et al. Somatic mutational landscape of extracranial arteriovenous malformations and phenotypic correlations. J Eur Acad Dermatol Venereol. 2022;36:905\u201312.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"770_CR5","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.ajhg.2017.01.018","volume":"100","author":"JA Couto","year":"2017","unstructured":"Couto JA, Huang AY, Konczyk DJ, Goss JA, Fishman SJ, Mulliken JB, et al. Somatic MAP2K1 mutations are associated with extracranial arteriovenous malformation. Am J Hum Genet. 2017;100:546\u201354.","journal-title":"Am J Hum Genet"},{"key":"770_CR6","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1172\/JCI98589","volume":"128","author":"L Al-Olabi","year":"2018","unstructured":"Al-Olabi L, Polubothu S, Dowsett K, Andrews KA, Stadnik P, Joseph AP, et al. Mosaic RAS\/MAPK variants cause sporadic vascular malformations which respond to targeted therapy. J Clin Investig. 2018;128:1496\u2013508.","journal-title":"J Clin Investig"},{"key":"770_CR7","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1016\/j.ajhg.2015.11.011","volume":"97","author":"N Limaye","year":"2015","unstructured":"Limaye N, Kangas J, Mendola A, Godfraind C, Schl\u00f6gel MJ, Helaers R, et al. Somatic activating PIK3CA mutations cause venous malformation. Am J Hum Genet. 2015;97:914\u201321.","journal-title":"Am J Hum Genet"},{"key":"770_CR8","doi-asserted-by":"publisher","first-page":"332ra42","DOI":"10.1126\/scitranslmed.aaf1164","volume":"8","author":"P Castel","year":"2016","unstructured":"Castel P, Carmona FJ, Grego-Bessa J, Berger MF, Viale A, Anderson KV, et al. Somatic PIK3CA mutations as a driver of sporadic venous malformations. Sci Transl Med. 2016;8:332ra42.","journal-title":"Sci Transl Med."},{"key":"770_CR9","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/j.jvsv.2020.07.015","volume":"9","author":"M Palmieri","year":"2021","unstructured":"Palmieri M, Di Sarno L, Tommasi A, Curr\u00f2 A, Doddato G, Baldassarri M, et al. MET somatic activating mutations are responsible for lymphovenous malformation and can be identified using cell-free DNA next generation sequencing liquid biopsy. J Vasc Surg Venous Lymphat Disord. 2021;9:740\u20134.","journal-title":"J Vasc Surg Venous Lymphat Disord"},{"key":"770_CR10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0200343","volume":"13","author":"H Blesinger","year":"2018","unstructured":"Blesinger H, Kaulfu\u00df S, Aung T, Schwoch S, Prantl L, R\u00f6\u00dfler J, et al. PIK3CA mutations are specifically localized to lymphatic endothelial cells of lymphatic malformations. PLoS ONE. 2018;13: e0200343.","journal-title":"PLoS ONE"},{"key":"770_CR11","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1093\/hmg\/ddu505","volume":"24","author":"AJ Osborn","year":"2015","unstructured":"Osborn AJ, Dickie P, Neilson DE, Glaser K, Lynch KA, Gupta A, et al. Activating PIK3CA alleles and lymphangiogenic phenotype of lymphatic endothelial cells isolated from lymphatic malformations. Hum Mol Genet. 2015;24:926\u201338.","journal-title":"Hum Mol Genet"},{"key":"770_CR12","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1186\/s13023-021-01929-8","volume":"16","author":"G Canaud","year":"2021","unstructured":"Canaud G, Hammill AM, Adams D, Vikkula M, Keppler-Noreuil KM. A review of mechanisms of disease across PIK3CA-related disorders with vascular manifestations. Orphanet J Rare Dis. 2021;16:306.","journal-title":"Orphanet J Rare Dis"},{"key":"770_CR13","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1007\/s10456-020-09722-0","volume":"23","author":"TD Le Cras","year":"2020","unstructured":"Le Cras TD, Goines J, Lakes N, Pastura P, Hammill AM, Adams DM, et al. Constitutively active PIK3CA mutations are expressed by lymphatic and vascular endothelial cells in capillary lymphatic venous malformation. Angiogenesis. 2020;23:425\u201342.","journal-title":"Angiogenesis"},{"key":"770_CR14","doi-asserted-by":"publisher","first-page":"1446046","DOI":"10.3389\/fmed.2024.1446046","volume":"11","author":"G Kane","year":"2024","unstructured":"Kane G, Fernandez-Pineda I. Targeted therapies for vascular malformations. Front Med. 2024;11:1446046.","journal-title":"Front Med"},{"key":"770_CR15","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.cps.2010.08.005","volume":"38","author":"AK Greene","year":"2011","unstructured":"Greene AK, Orbach DB. Management of arteriovenous malformations. Clin Plast Surg. 2011;38:95\u2013106.","journal-title":"Clin Plast Surg"},{"key":"770_CR16","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1097\/PRS.0b013e3181d18070","volume":"125","author":"AS Liu","year":"2010","unstructured":"Liu AS, Mulliken JB, Zurakowski D, Fishman SJ, Greene AK. Extracranial arteriovenous malformations: natural progression and recurrence after treatment. Plast Reconstr Surg. 2010;125:1185\u201394.","journal-title":"Plast Reconstr Surg"},{"key":"770_CR17","doi-asserted-by":"publisher","first-page":"2961","DOI":"10.1016\/j.jtha.2024.07.013","volume":"22","author":"E Seront","year":"2024","unstructured":"Seront E, Hermans C, Boon LM, Vikkula M. Targeted treatments for vascular malformations: current state of the art. J Thromb Haemost. 2024;22:2961\u201375.","journal-title":"J Thromb Haemost"},{"key":"770_CR18","doi-asserted-by":"publisher","first-page":"1099328","DOI":"10.3389\/fneur.2023.1099328","volume":"14","author":"A Mansur","year":"2023","unstructured":"Mansur A, Radovanovic I. Vascular malformations: an overview of their molecular pathways, detection of mutational profiles and subsequent targets for drug therapy. Front Neurol. 2023;14:1099328.","journal-title":"Front Neurol"},{"key":"770_CR19","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.jvssci.2020.08.002","volume":"1","author":"M Palmieri","year":"2020","unstructured":"Palmieri M, Curr\u00f2 A, Tommasi A, Di Sarno L, Doddato G, Baldassarri M, et al. Cell-free DNA next-generation sequencing liquid biopsy as a new revolutionary approach for arteriovenous malformation. JVS Vasc Sci. 2020;1:176\u201380.","journal-title":"JVS Vasc Sci."},{"key":"770_CR20","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1038\/s41591-023-02364-x","volume":"29","author":"D Li","year":"2023","unstructured":"Li D, Sheppard SE, March ME, Battig MR, Surrey LF, Srinivasan AS, et al. Genomic profiling informs diagnoses and treatment in vascular anomalies. Nat Med. 2023;29:1530\u20139.","journal-title":"Nat Med"},{"key":"770_CR21","doi-asserted-by":"publisher","first-page":"3740","DOI":"10.3390\/jcm11133740","volume":"11","author":"VB Serio","year":"2022","unstructured":"Serio VB, Palmieri M, Loberti L, Granata S, Fallerini C, Vaghi M, et al. Nosological and theranostic approach to vascular malformation through cfDNA NGS liquid biopsy. J Clin Med. 2022;11:3740.","journal-title":"J Clin Med"},{"key":"770_CR22","doi-asserted-by":"publisher","first-page":"1801371","DOI":"10.1183\/13993003.01371-2018","volume":"53","author":"M Eyries","year":"2019","unstructured":"Eyries M, Montani D, Nadaud S, Girerd B, Levy M, Bourdin A, et al. Widening the landscape of heritable pulmonary hypertension mutations in paediatric and adult cases. Eur Respir J. 2019;53:1801371.","journal-title":"Eur Respir J"},{"key":"770_CR23","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/s41436-020-00943-8","volume":"23","author":"K Zenner","year":"2021","unstructured":"Zenner K, Jensen DM, Cook TT, Dmyterko V, Bly RA, Ganti S, et al. Cell-free DNA as a diagnostic analyte for molecular diagnosis of vascular malformations. Genet Med. 2021;23:123\u201330.","journal-title":"Genet Med"},{"key":"770_CR24","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1177\/1708538120936421","volume":"29","author":"M Palmieri","year":"2021","unstructured":"Palmieri M, Pinto AM, di Blasio L, Curr\u00f2 A, Monica V, Sarno LD, et al. A pilot study of next generation sequencing-liquid biopsy on cell-free DNA as a novel non-invasive diagnostic tool for Klippel\u2013Trenaunay syndrome. Vascular. 2021;29:85\u201391.","journal-title":"Vascular"},{"key":"770_CR25","doi-asserted-by":"publisher","first-page":"1213283","DOI":"10.3389\/fgene.2023.1213283","volume":"14","author":"VB Serio","year":"2023","unstructured":"Serio VB, Palmieri M, Innamorato S, Loberti L, Fallerini C, Ariani F, et al. Case report: PIK3CA somatic mutation leading to Klippel Trenaunay syndrome and multiple tumors. Front Genet. 2023;14:1213283.","journal-title":"Front Genet"},{"key":"770_CR26","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/978-1-0716-3271-0_11","volume-title":"Microfluidic systems for cancer diagnosis","author":"AJ Conde","year":"2023","unstructured":"Conde AJ, Keraite I, Leslie NR, Kersaudy-Kerhoas M. Microfluidic acoustic method for high yield extraction of cell-free DNA in low-volume plasma samples. In: Garcia-Cordero JL, Revzin A, editors. Microfluidic systems for cancer diagnosis. New York: Springer, US; 2023. p. 163\u201380."},{"key":"770_CR27","doi-asserted-by":"publisher","first-page":"4810","DOI":"10.1038\/s41598-019-41215-z","volume":"9","author":"Q Peng","year":"2019","unstructured":"Peng Q, Xu C, Kim D, Lewis M, DiCarlo J, Wang Y. Targeted single primer enrichment sequencing with single end duplex-UMI. Sci Rep. 2019;9:4810.","journal-title":"Sci Rep"},{"key":"770_CR28","doi-asserted-by":"publisher","first-page":"2718","DOI":"10.1093\/bioinformatics\/btaa053","volume":"36","author":"V Sater","year":"2020","unstructured":"Sater V, Viailly P-J, Lecroq T, Prieur-Gaston \u00c9, Bohers \u00c9, Viennot M, et al. UMI-VarCal: a new UMI-based variant caller that efficiently improves low-frequency variant detection in paired-end sequencing NGS libraries. Bioinformatics. 2020;36:2718\u201324.","journal-title":"Bioinformatics"},{"key":"770_CR29","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1186\/s13023-021-01898-y","volume":"16","author":"P Brouillard","year":"2021","unstructured":"Brouillard P, Schl\u00f6gel MJ, Homayun Sepehr N, Helaers R, Queisser A, Fastr\u00e9 E, et al. Non-hotspot PIK3CA mutations are more frequent in CLOVES than in common or combined lymphatic malformations. Orphanet J Rare Dis. 2021;16:267.","journal-title":"Orphanet J Rare Dis"},{"key":"770_CR30","volume":"4","author":"Y Sun","year":"2023","unstructured":"Sun Y, Cai R, Wang Z, Wang D, Zhao X, Yue X, et al. Plasma cell-free DNA after embolization: a novel, sensitive method for the molecular diagnosis of venous malformations. J Vasc Anom. 2023;4: e054.","journal-title":"J Vasc Anom."},{"key":"770_CR31","first-page":"767","volume":"53","author":"M Pang","year":"2024","unstructured":"Pang M, Zhang G, Shang C, Zhang Y, Chen R, Li Z, et al. Advances in the study of KRAS in brain arteriovenous malformation. Cerebrovasc Dis Basel Switz. 2024;53:767\u201375.","journal-title":"Cerebrovasc Dis Basel Switz."},{"key":"770_CR32","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1056\/NEJMoa1709449","volume":"378","author":"SI Nikolaev","year":"2018","unstructured":"Nikolaev SI, Vetiska S, Bonilla X, Boudreau E, Jauhiainen S, Rezai Jahromi B, et al. Somatic activating KRAS mutations in arteriovenous malformations of the brain. N Engl J Med. 2018;378:250\u201361.","journal-title":"N Engl J Med"},{"key":"770_CR33","doi-asserted-by":"publisher","first-page":"e1365","DOI":"10.1016\/j.wneu.2019.03.105","volume":"126","author":"M Oka","year":"2019","unstructured":"Oka M, Kushamae M, Aoki T, Yamaguchi T, Kitazato K, Abekura Y, et al. KRAS G12D or G12V mutation in human brain arteriovenous malformations. World Neurosurg. 2019;126:e1365\u201373.","journal-title":"World Neurosurg."},{"key":"770_CR34","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1093\/brain\/awy307","volume":"142","author":"T Hong","year":"2019","unstructured":"Hong T, Yan Y, Li J, Radovanovic I, Ma X, Shao YW, et al. High prevalence of KRAS\/BRAF somatic mutations in brain and spinal cord arteriovenous malformations. Brain. 2019;142:23\u201334.","journal-title":"Brain"},{"key":"770_CR35","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1056\/NEJMoa1917239","volume":"383","author":"DS Hong","year":"2020","unstructured":"Hong DS, Fakih MG, Strickler JH, Desai J, Durm GA, Shapiro GI, et al. KRAS G12C inhibition with sotorasib in advanced solid tumors. N Engl J Med. 2020;383:1207\u201317.","journal-title":"N Engl J Med"},{"key":"770_CR36","doi-asserted-by":"publisher","first-page":"1030232","DOI":"10.3389\/fonc.2022.1030232","volume":"12","author":"G Mauri","year":"2022","unstructured":"Mauri G, Patelli G, Gori V, Lauricella C, Mussolin B, Amatu A, et al. Case report: MAP2K1 K57N mutation is associated with primary resistance to anti-EGFR monoclonal antibodies in metastatic colorectal cancer. Front Oncol. 2022;12:1030232.","journal-title":"Front Oncol"},{"key":"770_CR37","doi-asserted-by":"publisher","first-page":"36041","DOI":"10.18632\/oncotarget.5936","volume":"6","author":"R Murali","year":"2015","unstructured":"Murali R, Chandramohan R, M\u00f6ller I, Scholz SL, Berger M, Huberman K, et al. Targeted massively parallel sequencing of angiosarcomas reveals frequent activation of the mitogen activated protein kinase pathway. Oncotarget. 2015;6:36041\u201352.","journal-title":"Oncotarget"},{"key":"770_CR38","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.3390\/biomedicines12061289","volume":"12","author":"A Mansur","year":"2024","unstructured":"Mansur A, Radovanovic I. Defining the role of oral pathway inhibitors as targeted therapeutics in arteriovenous malformation care. Biomedicines. 2024;12:1289.","journal-title":"Biomedicines."},{"key":"770_CR39","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1056\/NEJMoa2309160","volume":"391","author":"A Fraissenon","year":"2024","unstructured":"Fraissenon A, Bayard C, Morin G, Benichi S, Hoguin C, Protic S, et al. Sotorasib for vascular malformations associated with KRAS G12C mutation. N Engl J Med. 2024;391:334\u201342.","journal-title":"N Engl J Med"},{"key":"770_CR40","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2019-3206","volume":"146","author":"EA Edwards","year":"2020","unstructured":"Edwards EA, Phelps AS, Cooke D, Frieden IJ, Zapala MA, Fullerton HJ, et al. Monitoring arteriovenous malformation response to genotype-targeted therapy. Pediatrics. 2020;146: e20193206.","journal-title":"Pediatrics"},{"key":"770_CR41","volume":"2","author":"DL Cooke","year":"2021","unstructured":"Cooke DL, Frieden IJ, Shimano KA. Angiographic evidence of response to trametinib therapy for a spinal cord arteriovenous malformation. J Vasc Anom. 2021;2: e018.","journal-title":"J Vasc Anom."},{"key":"770_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.gim.2023.100969","volume":"25","author":"G Canaud","year":"2023","unstructured":"Canaud G, Lopez Gutierrez JC, Irvine AD, Vabres P, Hansford JR, Ankrah N, et al. Alpelisib for treatment of patients with PIK3CA-related overgrowth spectrum (PROS). Genet Med. 2023;25: 100969.","journal-title":"Genet Med"},{"key":"770_CR43","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1158\/1078-0432.CCR-23-1270","volume":"30","author":"S Singh","year":"2024","unstructured":"Singh S, Bradford D, Li X, Mishra-Kalyani PS, Shen Y-L, Wang L, et al. FDA approval summary: alpelisib for PIK3CA-related overgrowth spectrum. Clin Cancer Res. 2024;30:23\u20138.","journal-title":"Clin Cancer Res"},{"key":"770_CR44","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1038\/s41392-024-01862-9","volume":"9","author":"L Zerbib","year":"2024","unstructured":"Zerbib L, Ladraa S, Fraissenon A, Bayard C, Firpion M, Venot Q, et al. Targeted therapy for capillary-venous malformations. Signal Transduct Target Ther. 2024;9:146.","journal-title":"Signal Transduct Target Ther"}],"container-title":["Molecular Diagnosis & Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40291-025-00770-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40291-025-00770-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40291-025-00770-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T20:02:14Z","timestamp":1746734534000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40291-025-00770-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,3]]},"references-count":44,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["770"],"URL":"https:\/\/doi.org\/10.1007\/s40291-025-00770-0","relation":{},"ISSN":["1177-1062","1179-2000"],"issn-type":[{"value":"1177-1062","type":"print"},{"value":"1179-2000","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,3]]},"assertion":[{"value":"19 January 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This work was supported by the rare disease network \u201cFAVA Multi\u201d, which funded in part the reactive costs for the molecular analysis.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Franck Neil El Sissy, Annouk Bisdorff, Alexandre Perrier, Erell Guillerm, J\u00e9r\u00f4me Denis, L\u00f6etitia Favre, Mathilde Aubertin, M\u00e9lanie Eyries, and Florence Coulet have no conflicts of interest that are directly relevant to the content of this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest\/competing interests"}},{"value":"The study was conducted in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all participants.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The data that support the findings of this study are available on request from the corresponding author.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and material"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"Franck Neil El Sissy, M\u00e9lanie Eyries, Florence Coulet, Alexandre Perrier, Erell Guillerm, J\u00e9r\u00f4me Denis, and L\u00f6etitia Favre contributed to the data collection and analysis. AB and MA contributed to the data collection by realizing the samples. ME and FC contributed to the study design. FNES, FC, AB, and ME drafted the manuscript. All authors contributed to the article and approved the submitted version.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors\u2019 contributions"}}]}}